{
  "id": "8fdb57ab3da07614",
  "title": "STAT+: On Day 4 of JPM,\u00a0a chat with Regeneron\u2019s George Yancopoulos, an IPO forecast, and all eyes on J&J",
  "description": "It's the last special edition of The Readout at #JPM26 \u2014\u00a0full of news and notes about biotech.",
  "content": "It's the last special edition of The Readout at #JPM26 \u2014\u00a0full of news and notes about biotech.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/01/15/jpm-2026-day-4-top-stories-regeneron-fda-ipos-jnj/?utm_campaign=rss",
  "published_at": "2026-01-15T19:31:53+00:00",
  "fetched_at": "2026-01-16T00:24:08.160649+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ipo"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: On Day 4 of JPM,\u00a0a chat with Regeneron\u2019s George Yancopoulos, an IPO forecast, and all eyes on J&J",
    "description": "It's the last special edition of The Readout at #JPM26 \u2014\u00a0full of news and notes about biotech.",
    "url": "https://www.statnews.com/2026/01/15/jpm-2026-day-4-top-stories-regeneron-fda-ipos-jnj/?utm_campaign=rss",
    "published": "2026-01-15T19:31:53+00:00",
    "source": "STAT"
  }
}